PBT swung to NZ$54k profit as working-capital build offset earnings quality

Revenue grew 23.2% to NZ$1.3m, consistent with the historical mean. However, this earnings improvement did not translate to cash: operating working-capital absorbed NZ$0.2m in FY24, against a historical pattern of consistent releases averaging NZ$-0.2m—a NZ$0.4m swing versus the historical mean that pushed operating cash flow to NZ$-0.1m.

NPAT, attributable to shareholders, remained a small loss of NZ$7.5k, which diverges from the PBT profit line. The FY23 comparative is drawn from an amended annual report, adding a mild caveat to the precision of period-on-period comparisons. No dividend was declared, consistent with the company's stated policy.

The second-half shape was pronounced: with only 36.9% of revenue in HY24, the implied second half contributed approximately NZ$0.84m of revenue and NZ$72k of NPAT profit.

The NZ$0.2m working-capital build—driven primarily by a 43.8% increase in inventories to NZ$0.5m, equivalent to 124.8 inventory days versus 106.8 days in FY23—absorbed the cash benefit of the PBT turnaround entirely. Because the historical pattern shows working-capital consistently releasing cash (average NZ$-0.2m), this build is above the normal range and warrants scrutiny as to whether it reflects deliberate stocking or slow-moving inventory.

The PBT-to-NPAT gap requires explanation. PBT was a NZ$54k profit while attributable NPAT was a NZ$7.5k loss, a gap that is not explained by tax (the effective rate has been 0.0% consistently). The divergence most likely reflects minority interest or other below-the-line allocations, but the filing does not provide sufficient detail to confirm this. The cleaner operating read is PBT at +130.3%.

ROE improved materially but remains marginally negative. ROE of -1.7% compares with -38.8% in FY23 and a historical mean of -34.3%, placing it above the normal range. While the directional shift is significant, a still-negative ROE on a small equity base of NZ$0.4m means the business is not yet generating returns for shareholders.

The second-half weighting of both revenue and earnings is notable: the company generated approximately 63% of its annual revenue in the second half, and the full-year NPAT improvement was entirely a second-half phenomenon given HY24 reported a NZ$79k loss.

Without forward order book disclosure, it is not possible to assess whether the second-half revenue momentum is sustainable into FY25. The inventory build could signal confidence in near-term sales, or it could represent unsold stock—the release does not distinguish between these readings.

However, the quality of that result is undermined by cash generation: operating cash flow was NZ$-0.1m versus NZ$+62k in FY23, meaning the business consumed more cash as it grew. The inventory build of NZ$0.1m year-on-year is the proximate driver, and until inventory days normalise, the PBT improvement will not be visible in cash.

Pre-lease free cash flow of NZ$-0.1m is within the company's historical range (mean NZ$-0.2m), which limits concern about structural cash deterioration, but the prior comparable was unusually cash-generative, making the direction of travel less favourable than the headline suggests. The company's asset base (NZ$2.0m total assets) and borrowings (NZ$66k gross, down 20.5%) leave the balance sheet manageable, and leverage is strengthening.

This briefing cannot assess whether the inventory build reflects genuine forward demand or stock that is at risk of write-down, as no inventory aging or forward sales pipeline data was disclosed.